These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29685755)

  • 1. Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
    Carmona-Bayonas A; Jiménez-Fonseca P; Echavarria I; Sánchez Cánovas M; Aguado G; Gallego J; Custodio A; Hernández R; Viudez A; Cano JM; Martínez de Castro E; Macías I; Martín Carnicero A; Garrido M; Mangas M; Álvarez Manceñido F; Visa L; Azkarate A; Ramchandani A; Fernández Montes A; Longo F; Sánchez A; Pimentel P; Limón ML; Arias D; Cacho Lavin D; Sánchez Bayona R; Cerdá P; García Alfonso P;
    Eur J Surg Oncol; 2018 Aug; 44(8):1191-1198. PubMed ID: 29685755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
    Alvarez-Manceñido F; Jimenez-Fonseca P; Carmona-Bayonas A; Arrazubi V; Hernandez R; Cano JM; Custodio A; Pericay Pijaume C; Aguado G; Martínez Lago N; Sánchez Cánovas M; Cacho Lavin D; Visa L; Martinez-Torron A; Arias-Martinez A; López F; Limón ML; Vidal Tocino R; Fernández Montes A; Alsina M; Pimentel P; Reguera P; Martín Carnicero A; Ramchandani A; Granja M; Azkarate A; Martín Richard M; Serra O; Hernández Pérez C; Hurtado A; Gil-Negrete A; Sauri T; Morales Del Burgo P; Gallego J
    Gastric Cancer; 2021 Jul; 24(4):926-936. PubMed ID: 33651195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resection of advanced esophagogastric adenocarcinoma : Extended indications].
    Mönig SP; Schiffmann LM
    Chirurg; 2016 May; 87(5):398-405. PubMed ID: 27138270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study.
    Seesing MFJ; van der Veen A; Brenkman HJF; Stockmann HBAC; Nieuwenhuijzen GAP; Rosman C; van den Wildenberg FJH; van Berge Henegouwen MI; van Duijvendijk P; Wijnhoven BPL; Stoot JHMB; Lacle M; Ruurda JP; van Hillegersberg R;
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 31220859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-free interval length correlates to prognosis of patients who underwent metastasectomy for esophageal lung metastases.
    Shiono S; Kawamura M; Sato T; Nakagawa K; Nakajima J; Yoshino I; Ikeda N; Horio H; Akiyama H; Kobayashi K;
    J Thorac Oncol; 2008 Sep; 3(9):1046-9. PubMed ID: 18758309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery.
    Badgwell B; Roy-Chowdhuri S; Chiang YJ; Matamoros A; Blum M; Fournier K; Mansfield P; Ajani J
    J Surg Oncol; 2015 Jun; 111(7):875-81. PubMed ID: 25872485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction.
    de Manzoni G; Pedrazzani C; Pasini F; Durante E; Gabbani M; Grandinetti A; Guglielmi A; Griso C; Cordiano C
    Eur J Surg Oncol; 2003 Aug; 29(6):506-10. PubMed ID: 12875856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.
    Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
    Anticancer Res; 2015 Jan; 35(1):445-56. PubMed ID: 25550586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
    Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
    Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
    Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
    Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
    Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
    Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
    Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
    Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.